These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18816319)

  • 1. BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience.
    Bakos AD; Hutson SP; Loud JT; Peters JA; Giusti RM; Greene MH
    Health Expect; 2008 Sep; 11(3):220-31. PubMed ID: 18816319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproductive decision-making in young female carriers of a BRCA mutation.
    Donnelly LS; Watson M; Moynihan C; Bancroft E; Evans DG; Eeles R; Lavery S; Ormondroyd E
    Hum Reprod; 2013 Apr; 28(4):1006-12. PubMed ID: 23293217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast Cancer Risk Perceptions among Relatives of Women with Uninformative Negative BRCA1/2 Test Results: The Moderating Effect of the Amount of Shared Information.
    Himes DO; Clayton MF; Donaldson GW; Ellington L; Buys SS; Kinney AY
    J Genet Couns; 2016 Apr; 25(2):258-69. PubMed ID: 26245632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What Black Women Know and Want to Know About Counseling and Testing for BRCA1/2.
    Adams I; Christopher J; Williams KP; Sheppard VB
    J Cancer Educ; 2015 Jun; 30(2):344-52. PubMed ID: 25301325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress.
    Culver JO; Brinkerhoff CD; Clague J; Yang K; Singh KE; Sand SR; Weitzel JN
    Clin Genet; 2013 Nov; 84(5):464-72. PubMed ID: 23323793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Legacies and Relationships: Diverse Social Networks and BRCA1/2 Risk Management Decisions and Actions.
    Ersig AL; Werner-Lin A; Hoskins L; Young J; Loud JT; Peters J; Greene MH
    J Fam Nurs; 2019 Feb; 25(1):28-53. PubMed ID: 30537877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporating information regarding preimplantation genetic diagnosis into discussions concerning testing and risk management for BRCA1/2 mutations: a qualitative study of patient preferences.
    Hurley K; Rubin LR; Werner-Lin A; Sagi M; Kemel Y; Stern R; Phillips A; Cholst I; Kauff N; Offit K
    Cancer; 2012 Dec; 118(24):6270-7. PubMed ID: 22736296
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Sarig K; Oxley S; Kalra A; Sobocan M; Fierheller CT; Sideris M; Gootzen T; Ferris M; Eeles RA; Evans DG; Quaife SL; Manchanda R
    J Med Genet; 2024 Jun; 61(7):716-725. PubMed ID: 38575303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding Social, Cultural, and Religious Factors Influencing Medical Decision-Making on BRCA1/2 Genetic Testing in the Orthodox Jewish Community.
    Yi H; Trivedi MS; Crew KD; Schechter I; Appelbaum P; Chung WK; Allegrante JP; Kukafka R
    Public Health Genomics; 2024; 27(1):57-67. PubMed ID: 38402864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which BRCA genetic testing programs are ready for implementation in health care? A systematic review of economic evaluations.
    D'Andrea E; Marzuillo C; De Vito C; Di Marco M; Pitini E; Vacchio MR; Villari P
    Genet Med; 2016 Dec; 18(12):1171-1180. PubMed ID: 27906166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Men with metastatic prostate cancer carrying a pathogenic germline variant in breast cancer genes: disclosure of genetic test results to relatives.
    Vlaming M; Ausems MGEM; Schijven G; van Oort IM; Kets CM; Komdeur FL; van der Kolk LE; Oldenburg RA; Sijmons RH; Kiemeney LALM; Bleiker EMA
    Fam Cancer; 2024 Jun; 23(2):165-175. PubMed ID: 38722431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Communication processes about predictive genetic testing within high-risk breast cancer families: a two-phase study design.
    Blomen CL; Pott A; Volk AE; Budäus L; Witzel I
    Sci Rep; 2021 Oct; 11(1):20178. PubMed ID: 34635688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A statewide survey of practitioners to assess knowledge and clinical practices regarding hereditary breast and ovarian cancer.
    Pal T; Cragun D; Lewis C; Doty A; Rodriguez M; Radford C; Thompson Z; Kim J; Vadaparampil ST
    Genet Test Mol Biomarkers; 2013 May; 17(5):367-75. PubMed ID: 23448386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of risk information exposure on women's beliefs about direct-to-consumer genetic testing for BRCA mutations.
    Gray SW; Hornik RC; Schwartz JS; Armstrong K
    Clin Genet; 2012 Jan; 81(1):29-37. PubMed ID: 21992449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement and Influence of Healthcare Providers, Family Members, and Other Mutation Carriers in the Cancer Risk Management Decision-Making Process of BRCA1 and BRCA2 Mutation Carriers.
    Puski A; Hovick S; Senter L; Toland AE
    J Genet Couns; 2018 Sep; 27(5):1291-1301. PubMed ID: 29594659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: a qualitative analysis.
    Ormondroyd E; Donnelly L; Moynihan C; Savona C; Bancroft E; Evans DG; Eeles R; Lavery S; Watson M
    Eur J Hum Genet; 2012 Jan; 20(1):4-10. PubMed ID: 21811309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Maybe they have found something new" participants' views on returning cohort psychosocial survey results.
    Bureau E; Pellegrini I; Noguès C; Lasset C; Julian-Reynier C
    Health Expect; 2015 Dec; 18(6):2425-36. PubMed ID: 24889689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions to support decision making in people considering germline genetic testing for BRCA 1/2 pathogenic and likely pathogenic variants: A scoping review.
    Pozzar RA; Seven M
    J Genet Couns; 2024 Apr; 33(2):392-401. PubMed ID: 37328917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive families.
    Korde LA; Mueller CM; Loud JT; Struewing JP; Nichols K; Greene MH; Mai PL
    Breast Cancer Res Treat; 2011 Jan; 125(1):169-73. PubMed ID: 20458532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer.
    Cragun D; Bonner D; Kim J; Akbari MR; Narod SA; Gomez-Fuego A; Garcia JD; Vadaparampil ST; Pal T
    Breast Cancer Res Treat; 2015 May; 151(1):169-76. PubMed ID: 25868867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.